RESEARCHERS at Mebourne's Royal Women's Hospital and Victorian Cytology Service have found new Gardasil 9 vaccine protected against 93% of cervical cancers compared with 77% with the previous version, according to a paper published in the International Journal of Cancer.
Lead researcher, Associate Professor Julia Brotherton, said the work was "truly ground-breaking".
The Pharmaceutical Benefits Advisory Committee anticipates a decision on funding for the vaccine later this month, reports the ABC.
Gardasil 9, given at age 14 years, requires only two injections compared with the previous three.
The paper was published in the International Journal of Cancer.
The above article was sent to subscribers in Pharmacy Daily's issue from 14 Aug 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Aug 17